Stay updated on Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.

Latest updates to the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now shows Revision: v3.3.2, replacing Revision: v3.3.1.SummaryDifference0.1%

- Check22 days agoChange DetectedThe record history shows an added system revision v3.3.1 and a removed revision v3.2.0.SummaryDifference0.1%

- Check29 days agoChange DetectedThe government funding notice about data currency and operating status was removed from the page. The remainder of the page content and the study history table remain unchanged.SummaryDifference0.4%

- Check44 days agoChange DetectedThe version history shows updates to Study Status and Contacts/Locations across several versions, reflecting changes in recruitment status and site locations.SummaryDifference0.1%

- Check72 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removed old v3.1.0 label.SummaryDifference9%

- Check80 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab Safety, PK, and Efficacy in Multiple Myeloma Clinical Trial page.